30,000 people to enter final testing phase of COVID-19 vaccine


Share post:

An experimental vaccine developed by the National Institute of Health and Moderna Inc will start the final testing phase in the U.S. beginning with 30,000 people on July 27th.

The testing will be a key phase in the road to a vaccine against COVID-19.

“No matter how you slice this, this is good news,” Dr. Anthony Fauci, the U.S. government’s top infectious disease expert, told The Associated Press.

Fauci’s colleagues at the Institute are the developers behind the would be vaccine. The phase is being entered following a testing of 45 volunteers, who submitted to testing in March.  The goal of the vaccine is to offer an immune boost against the pandemic.

There are no guarantees to the virus, but it would require two doses, set two months apart to administer.

Side effects were reported with the drug with over half of participants reporting reactions uncommon to other vaccines, including fatigue, headache, chills, fever and pain at the injection site.


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Related articles

Former Assistant Warden at Stateville arrested last Wednesday in Kankakee 

KANKAKEE - A former assistant warden at Stateville Correctional Center was arrested last Wednesday on five alleged criminal sex...

BBCHS releases 2023 Illinois State Scholars List

BOURBONNAIS - Bradley Bourbonnais community high school has released the list of the school’s 2023 Illinois State Scholars.  The Illinois...

Man arrested after allegedly attacking Vehicle with Samurai Sword in Indiana 

WHEATFIELD - A man has been arrested on intimidation charges after allegedly attacking a vehicle with a Katana. According to...

Jeep vs. Garbage Truck crash on Route 50 sends three to Hospital

KANKAKEE - Three people were hospitalized after a crash Tuesday morning involving a garbage truck. According to Illinois State Police...